Magnesium sulfate treatment decreases the initial brain damage alterations produced after perinatal asphyxia in fetal lambs

J Neurosci Res. 2012 Oct;90(10):1932-40. doi: 10.1002/jnr.23091. Epub 2012 Jun 20.

Abstract

The aim of this work was to analyze the effect of MgSO(4) treatment in the brain after hypoxic-ischemic (HI) injury in premature fetal lambs. Injury was induced by partial occlusion of umbilical cord for 60 min, and then the preterm lambs (80-90% of gestation) were randomly assigned to one of the following groups: control group, in which the animals were managed by conventional mechanical ventilation for 3 hr; 3 hr postpartial cord occlusion (3-hr-PCO) group, in which injured animals were managed by ventilation and then sacrificed 3 hr after HI; and MgSO(4) group, in which animals received 400 mg/kg MgSO(4) for 20 min soon after HI was induced and were managed by ventilation for 3 hr. Brains were analyzed for apoptosis by TUNEL assay. Cell viability and intracellular state studies were assessed by flow cytometry. The delayed death index was significantly increased in the 3-hr-PCO group in comparison with control. Administration of MgSO(4) elicited a delay in cell death that was similar to that in the control group. The 3-hr-PCO group showed a significantly higher concentration of reactive oxygen species, mitochondrial damage, and intracellular calcium in comparison with control and MgSO(4) - treated groups. Our results suggest that MgSO(4) treatment might have potential therapeutic benefits after the HI event.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Animals, Newborn / physiology*
  • Annexin A5 / metabolism
  • Apoptosis / drug effects
  • Asphyxia / pathology*
  • Brain Damage, Chronic / pathology*
  • Brain Damage, Chronic / prevention & control*
  • Calcium / metabolism
  • Carotid Arteries / pathology
  • Cell Membrane / drug effects
  • Cell Membrane / ultrastructure
  • Female
  • Fetus / pathology
  • Fluorescent Dyes
  • Immunohistochemistry
  • In Situ Nick-End Labeling
  • Magnesium Sulfate / pharmacology*
  • Membrane Potentials / drug effects
  • Mitochondrial Membranes / drug effects
  • Pregnancy
  • Primed In Situ Labeling
  • Reactive Oxygen Species / metabolism
  • Rhodamine 123
  • Sheep
  • Spinal Cord / pathology

Substances

  • Annexin A5
  • Fluorescent Dyes
  • Reactive Oxygen Species
  • Rhodamine 123
  • Magnesium Sulfate
  • Calcium